Life Science News

18 June 2003 - Contract development manufacturing: New deal for purine antimetabolite to treat leukaemia

Bioenvision signs manufacturing and supply agreements with Ferro Pfanstiehl for production of clofarabine Bioenvision, Inc. has signed two separate agreements..  More >>

18 June 2003 - Biomanufacturing: Expansion of protein purification capacity at Laureate

Laureate Pharma L.P. is expanding its GMP purification capacity for protein biopharmaceuticals by commissioning a new, automated chromatography system. The..  More >>

18 June 2003 - BioProtein bolsters its IP position in therapeutic proteins from rabbit milk

BioProtein acquires licence rights from GTC Biotherapeutics French biotech, BioProtein Technologies (BPT), which specialises in producing therapeutic proteins..  More >>

17 June 2003 - AstraZeneca opens new $25m (£16m) life science facility in Macclesfield, UK

AstraZeneca’s Executive VP for Global Development, Dr Martin Nicklasson opened the company’s new research and development facilities, worth about US$25 million..  More >>

17 June 2003 - Safety of blood products: Intercept system inactivates virus of SARS family

Preliminary tests show that a new pathogen inactivation technology is effective against the human coronavirus Companies engaged in the processing and supply..  More >>

17 June 2003 - Valentis backs out of pAlliance - gets back on track with DSM

Valentis resumes earlier licence agreement with DSM Biologics and is granted two manufacturing patents A new deal between Valentis and DSM Biologics..  More >>

16 June 2003 - Metabolic target identified in type 2 diabetes and obesity research

Xcellsyz reports mode of action for new antidiabetic at the Amercian Diabetes Association meeting "Systems Biology used to identify target as GSK3" Xcellsyz..  More >>

16 June 2003 - Bugs Life: Fruit fly joins battle against mosquito borne dengue fever

Meridian to manufacture dengue fever vaccine under contract for Hawaii Biotech, Inc. using Drosophila cell expression at Viral Antigens, Inc. site. Meridian..  More >>

13 June 2003 - QuantiGene® - a new deal branches out into life science with accurate viral testing

Genospectra and Bayer announce an exclusive development and distribution deal for branched DNA gene expression technology in the life science and research..  More >>

12 June 2003 - FDA approval for site transfer of arsenical manufacturing and supply to UK

CP Pharmaceuticals to supply Trisenox® FDA approves supplemental NDA for alternative manufacturing, labelling and testing sites for Trisenox Seattle-based..  More >>

11 June 2003 - Model mouse trap shrinks advanced cancerous tumors

Regeneron’s VEGF trap causes shrinkage of established tumors and metastases in preclinical studies Regeneron Pharmaceuticals, Inc. has reported that teams of..  More >>

10 June 2003 - £85m injection to increase vaccine production facilities in Liverpool, UK

Strategic investment by PowderJect will enhance vaccine development and boost manufacturing capability PowderJect Pharmaceuticals Plc with offices in..  More >>